[Autologous blood donation with preliminary erythropoietin stimulation].
Low basal hemoglobin and functional iron deficiency are the limiting factors in autologous blood donation program. Treatment with recombinant human erythropoietin can increase the volume of autologous blood and makes donation of > or = 3 units possible-even in patients with low basal hemoglobin. Best results are obtained if stimulation begins already one week before first donation.
Sipurzynski-Budrass
S
S
Department für Transfusionsmedizin und Immunhämatologie, Chirurgische Universitätsklinik, LKH Graz, Osterreich.
Posch
U
U
Stubenvoll
E
E
Gombotz
H
H
Lanzer
G
G
D018798:Anemia, Iron-Deficiency / Q000097:blood / Q000628:therapy; D001804:Blood Transfusion, Autologous; D017707:Erythrocyte Transfusion; D004911:Erythrocyte Volume; D004921:Erythropoietin / Q000008:administration & dosage*; D006452:Hemoglobinometry; D006801:Humans; D007501:Iron / Q000008:administration & dosage; D011292:Premedication; D011994:Recombinant Proteins
D011994:Recombinant Proteins; D004921:Erythropoietin; D007501:Iron
Eigenblutspende bei zeitgerechter Erythropoetinstimulation.